Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2578853 | Thérapie | 2014 | 6 Pages |
Abstract
Hyponatremia is a rare side effect described in the product characteristics of proton pump inhibitors (PPIs). Hyponatremia in the elderly (> 65 years) was assessed in patients with exposure to PPIs for at least one year compared to controls not exposed to PPIs counterparts. Included 145 patients, twenty-four patients (16.6%) had moderate hyponatremia ([120-134] mEq/L). Forty-eight patients (33.1%) were treated with PPIs. In the end, 31.3% [18.7%-46.3%] of the treated population for more than a year by PPI suffered moderate hyponatremia against only 9.3% [14.3%-16.9%] in the rest of the population, giving an odds ratio of 4.4 ([1.8-11.1], p = 0.001). The relationship between hyponatremia dose was not significant (R2 = 0.05, p = 0.74). By our study, we show that the risk of moderate hyponatremia is increased by chronic use of PPI in the elderly population. We also specify a notion of prevalence between 18.7% and 46.3%.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
Laure Peyro Saint Paul, Jocelyne Martin, Marie Buon, Cathy Gaillard, Sophie Fedrizzi, Brigitte Mosquet, Antoine Coquerel,